Vol 1 No 1 (2022): Tumor Discovery
Toggle navigation
Register
Login
Tumor Discovery
Vol 1 No 1 (2022)
Tumor Discovery
Published on March 10, 2022
Original research article
The clinicopathological and prognostic significance of PD-1 expression in cancers: A bioinformatics analysis
Shuai Shi, Zhi-Gang Zhang, Guan-ying Ma, Hong-Yan Ma
DOI:
10.36922/td.v1i1.59
Dual-targeting and specific delivery of tamoxifen to cancer cells by modified magnetic nanoparticles using hyaluronic acid and folic acid
Mostafa Heidari Majd
DOI:
10.36922/td.v1i1.41
Review article
Monocytes in tumor: from the sight of Single-cell analysis
Xin Fu, Mingzhu Yin
DOI:
10.36922/td.v1i1.4
Advances in the study of the pathogenesis of cancer-related cognitive impairment
Jiwei Jiang, Zhongli Du, Yanli Wang, Hanping Shi, Wenyi Li, Yuan Zhang, Mengfan Sun, Zhimin Bian, Jun Xu
DOI:
10.36922/td.v1i1.46
Case report
Combined anti-PD1 immunotherapy for patient with advanced pancreatic cancer: A case report
Zhe Jiang, Hongyan Li, Fei Li
DOI:
10.36922/td.v1i1.52
Editorial
Editor’s foreword to the inaugural issue of Tumor Discovery
Mingzhu Yin
DOI:
10.36922/td.v1i1.86
Information
For Readers
For Authors
For Librarians